Expression of Serine/glycine Metabolism-related Proteins is Different According to the Thyroid Cancer Subtype

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2016 Jun 10

PMID 27277113

Citations 36

Authors

Woo Young Sun

Hye Min Kim

Woo-Hee Jung

Ja Seung Koo

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to investigate the expression and clinical implications of proteins related to serine/glycine metabolism in different subtypes of thyroid cancer.

Methods: Tissue microarray (TMA) was constructed with tissues from 557 thyroid cancers, consisting of 244 papillary thyroid carcinomas (PTC), 112 follicular carcinomas (FC), 70 medullary carcinomas (MC), 23 poorly differentiated carcinomas (PDC), and 8 anaplastic carcinomas (AC). Immunohistochemical staining of the serine/glycine metabolism-related molecules phosphoglycerate dehydrogenase (PHGDH), phosphoserine aminotransferase, (PSAT), phosphoserine phosphatase (PSPH), serine hydromethyl transferase (SHMT), and glycine decarboxylase (GLDC) was performed with the TMA blocks and the results were analyzed together with clinicopathologic parameters.

Results: The expression of serine/glycine metabolism-related proteins differed among thyroid cancer subtypes. The expression rate of PHGDH (p < 0.001), PSAT1 (p = 0.001), PSPH (p = 0.008), and tumoral SHMT1 (p < 0.001) was higher in PDC and PTC (78.3, 21.7, 21.7, 30.4 and 63.4, 18.6, 12.8, 31.4 %, respectively), and lowest in MC (15.7, 1.4, 0.0, 10.0 %). Stromal SHMT1 expression was highest in AC (62.5 %) and absent in all FC (p < 0.001). In PTC, positivity for PSPH (p = 0.041), tumoral SHMT1 (p = 0.018), and stromal SHMT1 (p < 0.001) expression was higher in the conventional type compared to follicular type (14.1 versus 2.5 %, 33.6 versus 15.0 %, 42.1 versus 10.0 %, respectively). BRAF V600E mutation was associated with a higher rate of PHGDH (p < 0.001), PSAT1 (p = 0.001), PSPH (p < 0.001), tumoral SHMT1 (p = 0.001), stromal SHMT1 (p < 0.001), and GLDC (p < 0.001) expression compared to non-mutant cases (73.5 versus 40.6 %, 23.1 versus 8.5 %, 17.6 versus 1.9 %, 37.0 versus 18.9 %, 45.8 versus 21.7 %, 21.8 versus 6.6 %, respectively). In univariate analysis, stromal SHMT1 expression was associated with shorter disease-free survival (p = 0.015) in follicular variant PTC, and GLDC positivity was associated with shorter overall survival (OS) in sclerotic stromal type (p = 0.002). In FC, minimally invasive type, PSPH positivity correlated with shorter OS (p = 0.045) and in MC, PHGDH positivity correlated with shorter OS (p = 0.034).

Conclusion: The expression of serine/glycine metabolism-related proteins differs among different thyroid cancer types, with a higher rate of expression in PDC and PTC, and lower rate of expression in MC. In PTC, the rate of expression is lower in the follicular variant and higher in cases with BRAF V600E mutation.

Citing Articles

Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy.

Wan Y, Li G, Cui G, Duan S, Chang S Mol Cancer. 2025; 24(1):74.

PMID: 40069775 PMC: 11895238. DOI: 10.1186/s12943-025-02263-4.

Bioinformatics analysis of PSAT1 loss identifies downstream pathways regulated in EGFR mutant NSCLC and a selective gene signature for predicting the risk of relapse.

Biyik-Sit R, Waigel S, Andreeva K, Rouchka E, Clem B Oncol Lett. 2024; 29(1):9.

PMID: 39512505 PMC: 11542166. DOI: 10.3892/ol.2024.14755.

PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability.

Jasani N, Xu X, Posorske B, Kim Y, Wang K, Vera O Cancer Res. 2024; 85(2):314-328.

PMID: 39495254 PMC: 11735329. DOI: 10.1158/0008-5472.CAN-24-2471.

MAPK-mediated PHGDH induction is essential for melanoma formation and represents an actionable vulnerability.

Jasani N, Xu X, Posorske B, Kim Y, Vera O, Tsai K bioRxiv. 2024; .

PMID: 38659816 PMC: 11042198. DOI: 10.1101/2024.04.11.589139.

Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses.

Lee S, Park S, Yi S, Choi N, Lim M, Chang J Nat Commun. 2024; 15(1):1163.

PMID: 38331894 PMC: 10853200. DOI: 10.1038/s41467-024-45366-0.

References

Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

Marino G, Kroemer G . Ammonia: a diffusible factor released by proliferating cells that induces autophagy. Sci Signal. 2010; 3(124):pe19. DOI: 10.1126/scisignal.3124pe19. View

Eng C, Abraham R . Glutaminolysis yields a metabolic by-product that stimulates autophagy. Autophagy. 2010; 6(7):968-70. PMC: 3039742. DOI: 10.4161/auto.6.7.13082. View

Possemato R, Marks K, Shaul Y, Pacold M, Kim D, Birsoy K . Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011; 476(7360):346-50. PMC: 3353325. DOI: 10.1038/nature10350. View

Kim S, Jung W, Koo J . Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. PLoS One. 2014; 9(6):e101004. PMC: 4076239. DOI: 10.1371/journal.pone.0101004. View

KIKUCHI G . The glycine cleavage system: composition, reaction mechanism, and physiological significance. Mol Cell Biochem. 1973; 1(2):169-87. DOI: 10.1007/BF01659328. View

Bullock M, ONeill C, Chou A, Clarkson A, Dodds T, Toon C . Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma. Endocr Relat Cancer. 2012; 19(6):779-84. DOI: 10.1530/ERC-12-0239. View

Hirsch H, Greenberg D . Studies on phosphoserine aminotransferase of sheep brain. J Biol Chem. 1967; 242(9):2283-7. View

BORKENHAGEN L, Kennedy E . The enzymatic exchange of L-serine with O-phospho-L-serine catalyzed by a specific phosphatase. J Biol Chem. 1959; 234(4):849-53. View

10.

Sherman S . Thyroid carcinoma. Lancet. 2003; 361(9356):501-11. DOI: 10.1016/s0140-6736(03)12488-9. View

11.

Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza A . Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 2012; 336(6084):1040-4. PMC: 3526189. DOI: 10.1126/science.1218595. View

12.

Huang F, Zhang Q, Ma H, Lv Q, Zhang T . Expression of glutaminase is upregulated in colorectal cancer and of clinical significance. Int J Clin Exp Pathol. 2014; 7(3):1093-100. PMC: 3971313. View

13.

Ko Y, Lin Z, Flomenberg N, Pestell R, Howell A, Sotgia F . Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance. Cancer Biol Ther. 2012; 12(12):1085-97. PMC: 3335942. DOI: 10.4161/cbt.12.12.18671. View

14.

Liu X, Yan K, Lin X, Zhao L, An W, Wang C . The association between BRAF (V600E) mutation and pathological features in PTC. Eur Arch Otorhinolaryngol. 2014; 271(11):3041-52. DOI: 10.1007/s00405-013-2872-7. View

15.

Nagarajah J, Ho A, Tuttle R, Weber W, Grewal R . Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study. J Nucl Med. 2015; 56(5):662-7. PMC: 4970467. DOI: 10.2967/jnumed.114.150607. View

16.

Martinez-Outschoorn U, Pavlides S, Howell A, Pestell R, Tanowitz H, Sotgia F . Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol. 2011; 43(7):1045-51. PMC: 3102770. DOI: 10.1016/j.biocel.2011.01.023. View

17.

Choi J, Kim D, Jung W, Koo J . Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype. Breast Cancer Res. 2013; 15(5):R78. PMC: 3979011. DOI: 10.1186/bcr3472. View

18.

Henry L, Lee H, Lee J, Klein-Szanto A, Watts P, Ross E . Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007; 13(6):1736-41. DOI: 10.1158/1078-0432.CCR-06-1746. View

19.

Locasale J, Grassian A, Melman T, Lyssiotis C, Mattaini K, Bass A . Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011; 43(9):869-74. PMC: 3677549. DOI: 10.1038/ng.890. View

20.

Kim S, Jung W, Koo J . The expression of glutamine-metabolism-related proteins in breast phyllodes tumors. Tumour Biol. 2013; 34(5):2683-9. DOI: 10.1007/s13277-013-0819-7. View